Fact-checked by Grok 2 weeks ago

Lactococcus lactis

Lactococcus lactis is a Gram-positive, spherical coccus-shaped bacterium that belongs to the phylum Firmicutes, class Bacilli, order Lactobacillales, and family Streptococcaceae, characterized by its non-motile, non-spore-forming, and facultative anaerobic nature.^[1] It primarily ferments carbohydrates, such as lactose, into lactic acid through homolactic fermentation, enabling its essential role in dairy product production.^[2] With a genome size of approximately 2.3–2.5 million base pairs and a low G+C content of about 35 mol%, it exhibits genetic features that support rapid growth at temperatures between 10–40°C (optimum around 30°C) and the production of bacteriocins like nisin for antimicrobial activity.^[3] As a cornerstone of the dairy industry, L. lactis serves as a primary starter culture in the fermentation of cheeses (e.g., Cheddar), yogurts, and other fermented milks, where it drives acidification to lower pH, enhances texture through exopolysaccharide production, and develops complex flavors via volatile compounds and proteolysis.^[4] Recognized as generally regarded as safe (GRAS) by regulatory bodies like the FDA, it has been used for centuries in food preservation and imparts nutritional enhancements, including vitamins such as folate, riboflavin, and vitamin K2.^[2] The bacterium exists in subspecies like l. lactis subsp. lactis and cremoris, with dairy-adapted strains showing genome erosion and specialized genes for lactose metabolism and phage resistance, distinguishing them from plant-origin isolates.^[1] Beyond food applications, L. lactis has emerged as a versatile microbial cell factory in biotechnology due to its well-characterized genetics, plasmid-based systems, and food-grade status, enabling the production of recombinant proteins, therapeutics (e.g., interleukin-10 for inflammatory bowel disease), and vaccines.^[2] It also demonstrates probiotic potential, surviving gastrointestinal conditions (e.g., pH 2.5–3 and bile salts), modulating gut microbiota, reducing pathogens through bacteriocins, and offering health benefits like cholesterol reduction and immunostimulation when consumed at doses of 10⁶–10⁹ viable cells daily.^[4] These attributes underscore its transition from a traditional fermentative organism to a tool in modern industrial and health sciences.^[3]

Taxonomy and Classification

Species Description

Lactococcus lactis is a bacterial species classified within the genus Lactococcus in the family Streptococcaceae, order Lactobacillales, class Bacilli, and phylum Bacillota (formerly known as Firmicutes).^[5] Originally described as "Bacterium lactis" by Joseph Lister in 1873 based on its role in milk souring, it was reclassified as Streptococcus lactis in the early 20th century.^[6] In 1985, Karl-Heinz Schleifer and colleagues proposed the establishment of the genus Lactococcus to accommodate S. lactis and related taxa, distinguishing them from other streptococci through 16S rRNA sequencing, DNA-DNA hybridization, and phenotypic analyses that revealed significant genetic and physiological divergences, such as differences in peptidoglycan composition and fermentation patterns.^[7] The species is defined by key morphological and physiological traits that align with its lactic acid bacterial lineage. Lactococcus lactis consists of Gram-positive cocci that are spherical or ovoid in shape, typically arranged in pairs or chains, and measure approximately 0.5 to 1.2 μm in diameter.^[8] These bacteria are non-motile and non-spore-forming, exhibiting a facultative anaerobic metabolism that allows growth under both aerobic and anaerobic conditions, with optimal temperatures around 30°C.^[9] They are catalase-negative and homofermentative, primarily producing L-lactic acid from carbohydrate fermentation, which underscores their adaptation to nutrient-rich environments like plant material and dairy sources.^[10] The type strain for Lactococcus lactis is designated as Lactococcus lactis subsp. lactis NCDO 604, originally isolated from milk and now maintained as ATCC 19435 in culture collections worldwide; this strain serves as the reference for species identification and genomic studies.^[11]

Subspecies and Strains

As of 2021, Lactococcus lactis is classified into two subspecies: L. lactis subsp. lactis and L. lactis subsp. hordniae.^[6] The subspecies L. lactis subsp. lactis is mesophilic with optimal growth around 30°C and is widely employed as a starter culture in cheese production due to its rapid acidification activity through lactose fermentation to lactic acid. Within subsp. lactis, citrate-positive variants known as biovar diacetylactis are distinguished by their ability to ferment citrate, leading to the production of diacetyl, a key aroma compound responsible for buttery flavors in fermented dairy products.^[12]^[13] In contrast, the former L. lactis subsp. cremoris—important for flavor enhancement in cheeses like Cheddar through production of compounds such as diacetyl and acetoin—has been elevated to the species level as Lactococcus cremoris sp. nov.^[14]^[15] The subspecies L. lactis subsp. hordniae, isolated from the plant-hopper Agallia constricta, is less commonly associated with industrial applications.^[16] Notable strains include IL1403 and NZ9000, which serve as models in research. The strain IL1403, a plasmid-cured derivative of the industrial isolate IL594, was the first L. lactis genome to be fully sequenced in 2001, providing a foundational reference for genetic studies with its 2.37 Mb chromosome containing genes for carbohydrate metabolism and stress responses.^[17] NZ9000, derived from the plasmid-free laboratory strain MG1363 (originally classified as subsp. cremoris, now L. cremoris), is engineered with the nisin-controlled expression (NICE) system and functions as a primary host for heterologous protein production in biotechnological applications.^[18]^[19] Strains of L. lactis exhibit significant genetic and phenotypic variations, particularly in plasmid content, which influences traits like phage resistance and lactose metabolism. Plasmids in dairy-adapted strains, such as those in subsp. lactis, often encode lactose fermentation operons (e.g., lac operon for β-galactosidase activity) and citrate utilization pathways, enabling efficient milk sugar breakdown.^[20]^[21] Phage resistance mechanisms, including abortive infection (Abi) systems like AbiB and AbiD1, are predominantly plasmid-borne and differ among strains; for instance, industrial isolates may carry multiple such plasmids, conferring broad insensitivity to lytic phages that threaten fermentation.^[22]^[23] In industrial applications, strain selection prioritizes rapid acid production rates to ensure timely coagulation in dairy fermentations, alongside bacteriophage insensitivity to maintain process reliability. High-performing strains, such as those with optimized acidification (e.g., reaching pH 5.2 in 6 hours in milk), are chosen for their balance of these traits, often derived from natural variants with enhanced plasmid-encoded defenses against common phages like those in the 936 or c2 families.^[4]^[24]

Biology and Physiology

Morphology and Cellular Structure

Lactococcus lactis cells are Gram-positive cocci with a spherical to ovoid shape, typically measuring 0.5 to 1.5 μm in diameter, and they commonly occur as single cells, pairs, or short chains of 2 to 20 cells depending on strain and growth conditions.^[3]^[4] The arrangement in chains arises from incomplete separation during cell division, a feature observed across various strains.^[25] The cellular envelope features a thick peptidoglycan layer characteristic of Gram-positive bacteria, which provides mechanical strength and shape maintenance, supplemented by teichoic acids that anchor to the peptidoglycan and promote adhesion to surfaces and other cells.^[26]^[27] These teichoic acids, including lipoteichoic acids linked to the cytoplasmic membrane, constitute a minor phosphorus component (<1%) but play key roles in cell wall organization and interactions.^[26] L. lactis lacks spores for survival under stress, flagella for motility, and true capsules, though a protective polysaccharide pellicle covers the surface in wild-type strains, masking the underlying peptidoglycan.^[28] Surface proteins, including pili-like structures, are present and enable biofilm formation by facilitating cell aggregation and attachment to substrates.^[28] Electron microscopy reveals a smooth, featureless surface morphology in wild-type L. lactis cells, with the peptidoglycan organized into 25-nm-wide oblique bands beneath the polysaccharide layer, as visualized by atomic force microscopy on live cells.^[26] In mutants lacking surface polysaccharides, the exposed peptidoglycan shows a more irregular nanoscale texture, highlighting the protective role of the outer layer.^[26] Transmission electron microscopy of dividing cells occasionally shows invaginations of the cytoplasmic membrane, interpreted as mesosome-like structures involved in septation, while the lactate dehydrogenase enzyme is primarily localized in the cytoplasm adjacent to the membrane for efficient pyruvate reduction.^[29]^[30]

Growth Conditions and Metabolism

Lactococcus lactis is a mesophilic bacterium with an optimal growth temperature of approximately 30°C, though it can grow over a range of 10–40°C depending on the strain.^[31] It thrives at a pH between 6.0 and 6.9, with initial media pH often adjusted to around 7.0 to support robust proliferation before acidification occurs.^[32] As a facultative anaerobe, L. lactis prefers microaerophilic conditions for growth but can shift to fermentative metabolism under strict anaerobiosis or respire when heme is available in the medium.^[33] The metabolism of L. lactis is predominantly homofermentative, converting carbohydrates such as lactose or glucose into lactic acid through the Embden-Meyerhof-Parnas (glycolysis) pathway.^[34] This process yields approximately 90% L(+)-lactic acid as the primary end product, with minor byproducts like acetate or ethanol formed under aerobic or stressed conditions.^[35] The high optical purity of L(+)-lactic acid distinguishes L. lactis from heterofermentative lactic acid bacteria. Key enzymes facilitate lactose catabolism: lactose is transported into the cell via the lactose-specific phosphotransferase system (Lac-PTS), followed by hydrolysis of the phosphorylated form by phospho-β-galactosidase (LacG) to yield glucose-6-phosphate and galactose-6-phosphate, which enters the tagatose-6-phosphate pathway.^[36] Lactate dehydrogenase (Ldh) then reduces pyruvate to L(+)-lactic acid, regenerating NAD⁺ essential for continued glycolysis.^[37] L. lactis requires specific nutrients for growth, including carbohydrates like lactose or glucose as carbon and energy sources, along with peptides and amino acids for protein synthesis.^[38] It is auxotrophic for several vitamins, notably riboflavin and pantothenate, which must be supplied externally due to incomplete biosynthetic pathways.^[38] Additionally, L. lactis cannot synthesize heme and relies on exogenous sources to enable cytochrome-mediated respiration under oxygen exposure.^[39] To cope with acidification during growth, L. lactis employs stress responses including acid tolerance via the F₀F₁-ATPase, which pumps protons out of the cell using ATP hydrolysis to maintain intracellular pH homeostasis. Strain variations may influence metabolic efficiency, such as altered lactic acid yields in adapted isolates.^[40]

Industrial Applications in Food

Role in Dairy Fermentation

Lactococcus lactis serves as a primary starter culture in the production of various dairy products, particularly cheeses such as Cheddar and Gouda, where it drives rapid acidification of milk through homolactic fermentation of lactose into lactic acid.^[37] This process typically lowers the pH from approximately 6.7 to 5.2–5.5 within 4–6 hours at 30°C, promoting the coagulation of milk proteins like casein to form the curd essential for cheese structure.^[41] Strains of L. lactis subsp. lactis and subsp. cremoris are commonly employed in mesophilic starters for these semi-hard cheeses, ensuring consistent acid development during the initial manufacturing stages.^[42] Beyond acidification, L. lactis contributes to flavor and texture development via proteolytic activity and production of aroma compounds. The cell-envelope proteinase PrtP hydrolyzes caseins into oligopeptides, which are transported intracellularly and further broken down by peptidases, releasing free amino acids that serve as precursors for volatile flavor molecules and enhance cheese ripening.^[43] In L. lactis subsp. lactis biovar diacetylactis (also known as subsp. lactis var. diacetylactis), citrate metabolism yields diacetyl and acetaldehyde, key contributors to the buttery and creamy aromas in cheeses and cultured butters.^[44] These metabolic pathways, building on the bacterium's basic lactic acid fermentation, support the sensory profile without dominating the overall process.^[37] Historically, L. lactis has been integral to dairy fermentation since ancient times, with formalized use in 19th-century European cheesemaking through back-slopping of whey or fermented milk to propagate natural starters.^[42] However, bacteriophage infections have long challenged production by lysing starter cells and causing slow or failed acidification, leading to economic losses; mitigation strategies include rotating phage-resistant strains within multi-strain blends.^[42] In modern practices, defined-strain cultures—comprising specific, characterized isolates—are preferred over traditional undefined whey-based starters for their predictability, reduced phage risk, and scalability in direct-vat inoculation systems.^[42]

Use in Other Fermented Foods

Lactococcus lactis plays a role in vegetable fermentations such as sauerkraut and kimchi, often as part of a mixed microbial community that includes Leuconostoc species, where it contributes to acidity development and preservation through lactic acid production and bacteriocin activity like nisin. In sauerkraut production, L. lactis subsp. lactis strains have been isolated from commercial fermentations and used as starters to enhance fermentation consistency and inhibit spoilage organisms. Similarly, in kimchi, L. lactis strains act as starters to extend shelf life by suppressing pathogens such as Lactobacillus plantarum and Pediococcus pentosaceus via antimicrobial compounds.^[45]^[46]^[47] In fermented meat products like salami and sausages, L. lactis serves as a starter culture, contributing to microbial safety via bacteriocins and acidification, while also generating flavor compounds through lactate accumulation. Additionally, bacteriocin-producing L. lactis transconjugants have been incorporated into sausage fermentation to control Listeria monocytogenes growth in the presence of nitrite.^[48]^[49]^[50] For beverage fermentations, L. lactis participates in kefir production through symbiotic interactions with yeasts and other lactic acid bacteria, contributing to the acidification and textural properties of the final product. In kefir grains, L. lactis subsp. lactis is among the dominant species that drive the initial stages of milk fermentation, producing lactic acid and exopolysaccharides that influence viscosity. In some traditional beers, such as chicha, L. lactis forms part of the natural bacterial community alongside Lactobacillus and Leuconostoc species, aiding in carbohydrate fermentation during the process.^[51]^[52]^[53] Emerging applications of L. lactis extend to plant-based milk alternatives, where it is employed as a starter for fermenting oat, soy, and mung bean substrates to produce yogurt-like products with improved texture and nutritional profiles. These fermentations leverage L. lactis's ability to metabolize non-dairy carbohydrates, resulting in enhanced antioxidant capacities and sensory attributes comparable to dairy yogurts. Galactose-positive strains of L. lactis, often derived from nondairy environments, exhibit superior adaptation to these plant-derived sugars, enabling efficient acid production and flavor development in lactose-free media.^[54]^[55]^[56]^[57]

Biotechnological and Therapeutic Uses

Probiotic Properties and Health Benefits

_Lactococcus lactis exhibits probiotic properties that promote gut health primarily through adhesion to the intestinal mucosa and modulation of the microbiota. Certain strains produce mucus-binding proteins (MUBs), such as MbpL in L. lactis BGKP1 and Muc in L. lactis TIL448, which facilitate specific binding to mucin glycans in the intestinal mucus layer, enhancing transient colonization and persistence in the gastrointestinal tract.^[58] This adhesion mechanism supports competitive exclusion of pathogens and contributes to barrier function integrity. Additionally, L. lactis modulates the gut microbiota by producing bacteriocins like nisin, which inhibit the growth of pathogens such as Listeria monocytogenes through membrane disruption and pore formation, thereby reducing pathogen colonization without significantly altering commensal populations.^[59] The bacterium also demonstrates immunomodulatory effects, particularly through its surface polysaccharides, including exopolysaccharides (EPS). For instance, EPS from L. lactis Z-2 increases the expression of anti-inflammatory cytokines such as IL-10 and TGF-β in intestinal tissues, promoting immune tolerance and reducing pro-inflammatory responses.^[60] Specific strains, like L. lactis T-21 isolated from wild cranberries, exhibit anti-inflammatory properties; a 2024 randomized, double-blind, placebo-controlled study showed that daily intake of 25 mg T-21 improved skin conditions in individuals with atopic predisposition by reducing trans-epidermal water loss and enhancing skin brightness, indicating broader immunomodulatory benefits.^[61] Another strain, L. lactis LB 1022, upregulates IL-10 production in atopic dermatitis models, suppressing Th2 cytokines (IL-4, IL-5, IL-13) and alleviating allergic symptoms through Treg-mediated immune suppression.^[62] Therapeutic potential of L. lactis includes alleviation of allergies via natural IL-10 induction and cholesterol reduction through bile salt hydrolase (BSH) activity. In atopic dermatitis mouse models, L. lactis LB 1022 reduced IgE levels, mast cell infiltration, and histamine release, demonstrating anti-allergic effects independent of genetic modification.^[62] For lipid management, strains like L. lactis subsp. lactis exhibit BSH activity that deconjugates bile salts (e.g., 2.47 U/ml with taurocholate), leading to cholesterol assimilation (up to 43.7% by growing cells) and precipitation, which lowers intestinal cholesterol absorption and supports hypocholesterolemic effects.^[63] L. lactis holds a Generally Recognized as Safe (GRAS) status from the FDA, with multiple notices affirming its safety for use in food at levels up to 10^11 CFU per serving, and it lacks known virulence factors due to its non-pathogenic nature and long history in dairy fermentation.^[64] Human trials confirm high tolerance; for example, a randomized, double-blind study administered 1×10^10 CFU/day of L. lactis GCWB1176 for 8 weeks without adverse effects, supporting its safety profile.^[65] For probiotic delivery, L. lactis can be incorporated into fortified yogurts and cheeses, where immobilized cells maintain viability above 6 log CFU/g during refrigerated storage for up to 14 days, ensuring sustained health benefits.^[66]

Engineering for Vaccine and Drug Delivery

_Lactococcus lactis has been genetically engineered as a live vector for mucosal delivery of vaccines and therapeutic proteins, leveraging its generally recognized as safe (GRAS) status and ability to colonize the gastrointestinal tract. A key approach involves the use of nisin-inducible expression systems, such as the pNZ8048 plasmid, which allows controlled production of heterologous proteins like antigens upon addition of the inducer nisin. This vector incorporates the strong P_nisA promoter and the Usp45 secretion signal peptide to facilitate extracellular secretion of the target protein, enabling high-level expression without the need for antibiotic selection markers, thus maintaining its food-grade properties.^[67]^[68] Early demonstrations of L. lactis as a vaccine platform focused on mucosal immunization against tetanus, where recombinant strains expressing the tetanus toxin fragment C (TTFC) induced protective immunity in mice via nasal or oral routes. In a seminal 1997 study, nasal administration of L. lactis secreting TTFC elicited serum IgG and mucosal IgA responses, conferring survival against lethal toxin challenges in 80-100% of immunized mice. More recently, engineering efforts have targeted emerging pathogens, including SARS-CoV-2; preclinical studies from 2022-2024 have shown that oral or intranasal delivery of L. lactis expressing the COVID-19 spike protein or its receptor-binding domain triggers robust humoral and cellular immune responses in mice, including neutralizing antibodies and T-cell activation, positioning it as a needle-free vaccine candidate.^[69]^[70]^[71]^[72] Beyond vaccines, L. lactis has been modified for in situ drug delivery in the gut, particularly for treating autoimmune and inflammatory conditions. Strains engineered to secrete proinsulin have demonstrated potential in reversing type 1 diabetes in mouse models by promoting regulatory T-cell responses and reducing insulitis upon oral administration. Similarly, L. lactis secreting interleukin-10 (IL-10) has shown therapeutic efficacy in murine colitis models, reducing inflammation by 50% through local cytokine modulation, with a Phase I clinical trial in Crohn's disease patients confirming safety and feasibility of oral delivery in 2006.^[73]^[74]^[75] In a 2022 study, metabolic engineering of the lycopene biosynthesis pathway (via integration of crtEBI genes) enabled L. lactis to produce up to 1.5 mg/L of lycopene, an antioxidant that protects intestinal epithelial cells from reactive oxygen species stress, highlighting its role in targeted nutraceutical delivery.^[76] Recent advancements include an early clinical evaluation in 2025, where engineered L. lactis delivering therapeutic agents combined with radiotherapy in three patients with recurrent solid tumors led to tumor reduction and enhanced systemic immunity, demonstrating feasibility in cancer therapy.^[77] The advantages of L. lactis for these applications include its food-grade nature, absence of endotoxins (as a Gram-positive bacterium), and resilience in the gastrointestinal environment, with engineered strains achieving up to 70% survival through gastric and intestinal phases. However, challenges persist, such as rapid immune clearance by host defenses and limited persistence in the gut, which can reduce delivery efficiency and necessitate protective formulations like microencapsulation. Regulatory progress continues with ongoing preclinical evaluations for oral vaccines and advancing clinical applications in therapeutics as of 2025.^[78]^[79]^[80]

Genomics and Genetic Research

Genome Structure and Sequencing

The genome of Lactococcus lactis consists of a single circular chromosome with a size ranging from approximately 2.25 to 2.59 Mb across strains, encoding roughly 2,000 to 2,500 protein-coding genes, and an average G+C content of about 35% https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3650-5. Strains commonly harbor multiple plasmids, typically 1 to 8 in number and ranging from 2 to over 100 kb in size, with a lower G+C content of 30-40% compared to the chromosome; these plasmids often carry accessory genes such as the lactose operon (lacABC), which enables lactose metabolism in dairy environments https://academic.oup.com/femsre/article/30/2/243/2367769. The first complete genome sequence was reported for L. lactis subsp. lactis IL1403 in 2001, revealing a 2,365,589 bp chromosome with 2,311 predicted genes, 86% of which are protein-coding, along with 43 insertion sequence (IS) elements and integrated prophage regions https://www.ncbi.nlm.nih.gov/pmc/articles/PMC311110/. Key genomic features include CRISPR-Cas systems, which provide adaptive immunity against bacteriophages by incorporating spacer sequences from invading viral DNA, a critical defense mechanism in industrial fermentation settings where phage infections are common https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546414/. Mobile genetic elements such as IS elements and transposons are abundant, contributing to genomic plasticity and strain diversity through rearrangements and horizontal gene transfer; for instance, L. lactis subsp. cremoris genomes often exhibit more pseudogenes and IS elements, suggestive of ongoing genome decay and specialization https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3650-5. Comparative genomics highlights subspecies-specific adaptations: L. lactis subsp. lactis genomes are generally larger and retain more genes associated with rapid growth and metabolic versatility on diverse substrates, supporting faster acidification in varied environments https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.00004/full, whereas subsp. cremoris strains feature specialized clusters for flavor biosynthesis, including enhanced proteolysis and aminotransferase pathways that generate aroma compounds during cheese ripening https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3650-5. These differences underscore the evolutionary divergence between plant-associated ancestors and dairy-adapted lineages, with plasmids playing a key role in acquiring traits like lactose utilization unique to subsp. cremoris https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365430/.

Recent Genetic Modifications and Advances

Since the advent of CRISPR-Cas9 systems in the post-genomic era, targeted genome editing in Lactococcus lactis has advanced significantly, enabling precise knockouts and insertions to enhance industrial traits. From 2018 onward, researchers have developed one-plasmid-based CRISPR-Cas9 tools for efficient gene deletion in L. lactis, allowing for the investigation of stress-related pathways without relying on multiple vectors.^[81] For instance, CRISPR-associated transposon systems have been adapted for guide RNA-directed insertions, facilitating stable genomic modifications in strains used for fermentation.^[82] These tools have been applied to improve acid resistance, resulting in strains with significantly higher survival rates under low-pH conditions, as demonstrated in dairy simulation experiments.^[83] In synthetic biology, metabolic engineering of L. lactis has leveraged modular assembly techniques to construct multi-gene pathways, expanding its role beyond traditional fermentation. Golden Gate assembly has been employed to reconstitute complex biosynthetic operons, allowing seamless integration of heterologous genes.^[84] Recent efforts have focused on carotenoid biosynthesis via pathway optimization.^[85] These advancements build on core genome features like modular plasmid backbones, which facilitate rapid prototyping of engineered strains.^[21] Omics technologies have further illuminated genetic responses in L. lactis, with proteomics studies from 2024 revealing key regulators of stress adaptation. Quantitative proteomics of ccpA mutants under acid and oxidative stress identified over 200 differentially expressed proteins, including those in glycolysis and envelope remodeling, which enhance survival in fermented environments.^[86] Complementing this, metagenomic surveys of fermented foods have mapped L. lactis interactions in microbial consortia, revealing strain-specific adaptations like prophage-encoded resistance genes that dominate in dairy matrices.^[87] These insights from PMC-reviewed works underscore how omics data guide targeted modifications for robust starters.^[88] Looking ahead, computational approaches are emerging for L. lactis strain design, integrating multi-omics data to predict resilient variants.^[89] In therapeutic contexts, engineered L. lactis has been explored for delivering immunomodulators like IL-10 to address inflammatory conditions such as IBD.^[90] These strains, modified with CRISPR for stable expression, continue to show promise in preclinical models.^[91] Despite these advances, challenges persist in L. lactis genetic engineering, particularly plasmid instability, where curing rates can reach 50% during prolonged fermentation due to metabolic burden and replication conflicts.^[21] Regulatory hurdles for food-grade genetically modified organisms (GMOs) include stringent GRAS assessments, as antibiotic markers and foreign DNA raise containment concerns, limiting commercial deployment.^[92] Strategies like auxotrophic complementation and RM system bypassing are mitigating these issues, but integration into chromosomes remains essential for stability.^[93]

References

[1]
Comparative Genome Analysis of Lactococcus lactis Indicates Niche ...
Jan 30, 2019 · Lactococcus lactis is a non-motile, non-spore-forming, low G+C, Gram-positive lactic acid bacterium. It is used as a starter culture in the ...
[2]
A review on Lactococcus lactis: from food to factory
Apr 4, 2017 · One of the reasons L. lactis has emerged to become a successful microbial cell factory system is due to the wealth of genetic knowledge ...
[3]
Lactococcus Lactis - an overview | ScienceDirect Topics
Lactococcus lactis is a species of bacteria recognized for its role in fermenting dairy products, where it can produce volatile compounds that contribute to ...
[4]
Lactococcus lactis in Dairy Fermentation—Health-Promoting ... - MDPI
lactis is a vital microorganism in the dairy food fermentation industry due to its role in acidification, flavor development, and the creation of various dairy ...
[5]
https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=1358
[6]
Species: Lactococcus lactis - LPSN
Name: Lactococcus lactis (Lister 1873) Schleifer et al. 1986 Category: Species Proposed as: comb. nov. Basonym: "Bacterium lactis" Lister 1873
[7]
Lactococcus - an overview | ScienceDirect Topics
Lactococcus are gram-positive, catalase-negative, facultatively anaerobic, non-motile cocci, mesophilic bacterium with growth optimum around 30 °C. Several ...
[8]
Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to ...
Lactococcus. Bacteria of the genus Lactococcus are characterized by being Gram-positive cocci that occur singly, in pairs, or in a chain, are non-spore-forming, ...
[9]
Summary of Lactococcus lactis lactis IL1403, version 29.1 - BioCyc
Summary, Lactococcus lactis is a mesophilic, Gram-positive, non-motile, non-spore-forming, facultative anaerobe, previously Streptococcus lactis.Missing: cocci | Show results with:cocci
[10]
Lactococcus lactis subsp. lactis (Lister) Schleifer et al. - 19435 | ATCC
Lactococcus lactis subsp. lactis strain NCTC 6681 is a whole-genome sequenced bacterial type strain with applications in media testing and bioinformatics.
[11]
Unit 2a. General functions, characteristics and classification of LAB ...
Lactic acid bacteria are classified according to their optimum growth temperature and principal metabolites. Mesophilic LAB have optimum growth near 30°C and a ...
[12]
Microbial interactions shape cheese flavour formation - Nature
Dec 21, 2023 · We studied the roles of microbial interactions in flavour formation in a year-long Cheddar cheese making process, using a commercial starter culture.
[13]
The microbes that give Cheddar cheese its distinct flavour
Dec 21, 2023 · When it comes to flavour, L. cremoris seems to regulate the development of the chemicals diacetyl and acetoin, which provide a buttery flavour, ...
[14]
Technological properties of Lactococcus lactis subsp. lactis bv ... - NIH
Nov 16, 2019 · Lactococcus lactis subsp. lactis bv. diacetylactis strains are often used as starter cultures by the dairy industry due to their production ...
[15]
Activation of the Diacetyl/Acetoin Pathway in Lactococcus lactis ...
Lactococcal dairy strains are divided in two subspecies, cremoris and lactis, and a biovariety of the latter is called diacetylactis, due its ability to convert ...
[16]
The complete genome sequence of the lactic acid bacterium ...
The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001 May;11(5):731-53. doi: 10.1101/gr.gr-1697r ...
[17]
Lactococcus lactis, an Attractive Cell Factory for the Expression of ...
The most commonly used host strain for MP expression is the strain NZ9000. ... Lactococcus lactis M4, a potential host for the expression of heterologous ...
[18]
[PDF] NICE Expression System for Lactococcus lactis The ... - MoBiTec
lactis subsp. cremoris MG1363, a plasmid-free progeny of the dairy starter strain NCDO712. The most commonly used host strain is NZ9000. To construct this ...
[19]
Complete Sequences of Four Plasmids of Lactococcus lactis subsp ...
Lactococcus lactis strains are known to carry plasmids encoding industrially important traits. L. lactis subsp. cremoris SK11 is widely used by the dairy ...
[20]
The Lactococcus lactis Pan-Plasmidome - Frontiers
Lactococcal strains possess an arsenal of phage defense mechanisms, such as R-M systems and abortive infection (Abi) systems, many of which are plasmid-encoded.
[21]
The Plasmid Complement of Lactococcus lactis UC509.9 Encodes ...
Four distinct, plasmid-borne bacteriophage resistance systems were identified, including two abortive infection systems, AbiB and AbiD1, thereby supporting the ...
[22]
Identification of Four Phage Resistance Plasmids from Lactococcus ...
Using phages obtained from cheese factory whey, four of the strains were found to be highly phage resistant. One of these isolates, Lactococcus lactis subsp.
[23]
The art of strain improvement of industrial lactic acid bacteria without ...
Aug 31, 2014 · Methods will be described for improving the bacteriophage resistance of specific strains, improving their texture forming ability, increasing ...Introduction · Modifying Bacterial Cell... · Improving Stress ToleranceMissing: insensitivity | Show results with:insensitivity
[24]
Lactococcus lactis vs. cremoris: Growth & Survival in Cheddar Cheese
Jan 12, 2022 · Using a sterile blender to make the first dilution will reduce longer chains to an average of 2.3 to 3 cells per chain (Lowrie et al., 1972), ...
[25]
Imaging the nanoscale organization of peptidoglycan in living ...
Jun 15, 2010 · Using topographic imaging, we found that Lactococcus lactis wild-type cells display a smooth, featureless surface morphology, whereas mutant ...
[26]
Peptidoglycan Structure Analysis of Lactococcus lactis Reveals the ...
Detailed structural analysis of Lactococcus lactis peptidoglycan was achieved by identification of its constituent muropeptides separated by reverse phase ...
[27]
Genetics of Lactococci | Microbiology Spectrum - ASM Journals
Lactococcus lactis is a relatively simple bacterium, with a 2.4-Mbp genome. Many of its functions of interest are nonredundant, which facilitates functional ...
[28]
Formation of intracellular vesicles within the Gram+ Lactococcus ...
Nov 17, 2022 · Transmission electron microscopy (TEM) ultrastructural analysis. Lactococcus lactis bacteria were transferred to aluminium sample holders and ...
[29]
lactate dehydrogenase, from Lactococcus lactis - PMC - NIH
A gene (designated ldh) that encodes fructose-1,6-bisphosphate-activated L-(+)-lactate dehydrogenase was cloned from Lactococcus lactis subsp. lactis.Missing: electron mesosomes
[30]
Adaptation of Lactococcus lactis to high growth temperature leads to ...
Sep 21, 2015 · Lactococcus lactis is essential for most cheese making, and this mesophilic bacterium has its growth optimum around 30 °C. We have, through ...
[31]
https://scialert.net/fulltext/?doi=biotech.2006.481.488
[32]
Respiration Capacity of the Fermenting Bacterium Lactococcus ...
We confirmed that L. lactis is capable of respiratory growth, in agreement with earlier work (34). Respiration conditions result in improved growth and a ...
[33]
Lactococcus - Teuber - Major Reference Works - Wiley Online Library
Sep 14, 2015 · Lactococci are homofermentative lactic acid bacteria. During growth in milk, lactose is converted to lactic acid. Lactose is taken up by a PEP- ...<|control11|><|separator|>
[34]
[PDF] Lactic acid production by a strain of Lactococcus lactis subs lactis ...
Lactococcus are coccibacteria, which form chains of variable length, they have a homo-fermentative metabolism and produce exclusively L(+) lactic acid (Roissart ...
[35]
[PDF] Metabolic shifts in Lactococcus lactis
When internalized via the PTSLac (LacEF), lactose is phosphorylated and hydrolysed by phospho-β-galactosidase (LacG); the glucose. Page 6. CHAPTER TWO. 47.
[36]
A review on Lactococcus lactis: from food to factory - PMC
Apr 4, 2017 · In this article, we review recent technological advancements, challenges, future prospects and current diversified examples on the use of L. lactis as a ...
[37]
Nutritional requirements and media development for Lactococcus ...
Mar 14, 2014 · This study focuses on determining nutrient auxotrophies and minimizing media components (amino acids, vitamins, metal ions, buffers and additional compounds)Missing: carbohydrates peptides riboflavin pantothenate heme
[38]
Respiratory Physiology of Lactococcus lactis in Chemostat Cultures ...
Mar 2, 2020 · This study extends our knowledge of respiratory metabolism in L. lactis and its impact on frozen and freeze-dried starter culture products.
[39]
Investigation of Flavor-Forming Starter Lactococcus lactis subsp ...
Starter cultures used in the production of cheeses are typically composed of mesophilic lactic acid bacteria (LAB) having acidification activity, proteolytic ...<|separator|>
[40]
Mesophilic and Thermophilic Cultures Used in Traditional ...
Most cheese varieties require acidification of milk by a select group of bacteria called starters. They ferment lactose to lactic acid and in so doing aid ...
[41]
Editing of the Proteolytic System of Lactococcus lactis Increases Its ...
Milk fermentation processes executed by LAB are preferable ways to release these peptides because of the food grade safety status of these organisms. Moreover, ...
[42]
Fermentation Characteristics of Lactococcus lactis subsp. lactis ...
Aug 4, 2020 · Isolates of L. lactis subsp. lactis biovar diacetylactis ferment citrate, which contributes to flavor and aroma via the production of diacetyl. ...
[43]
DNA Fingerprinting of Lactic Acid Bacteria in Sauerkraut ... - NIH
Sauerkraut fermentation involves many physical, chemical, and microbiological ... Lactococcus lactis subsp. lactis, and Leuconostoc fallax (3, 19, 25) ...
[44]
Characterization of Two Nisin-Producing Lactococcus lactis subsp.
Feb 15, 1992 · Two Lactococcus lactis subsp. lactis strains, NCK400 and 1JH80, isolated from a commercial sauerkraut fermentation were shown to produce nisin.<|control11|><|separator|>
[45]
Extending the Shelf life of Kimchi with Lactococcus lactis Strain as a ...
Jun 30, 2015 · We previously isolated Lactococcus lactis that exhibits inhibitory activity against Lactobacillus plantarum,. Pediococcus pentosaceus, and Lb.
[46]
Nitrites in Cured Meats, Health Risk Issues, Alternatives to Nitrites
An estimation predicts that when the nitrite content in sausage fermented with Lactococcus lactis reached 100 ppm, the development of starter cultures and ...
[47]
[PDF] Role of Starter Cultures on the Safety of Fermented Meat Products
Apr 26, 2019 · Reduction of nitrate to nitrite in meat is made by nitrate ... by a Lactococcus lactis strain isolated from charqui, a Brazilian fermented, salted.
[48]
The Curing Agent Sodium Nitrite, Used in the Production of ... - NIH
Effect of nitrite on a bacteriocinogenic Lactococcus lactis transconjugant in fermented sausage. Eur. Food Res. Technol. 213:48-52. [Google Scholar]; 37 ...
[49]
The Microbiota and Health Promoting Characteristics of the ... - NIH
Kefir is a complex fermented dairy product created through the symbiotic fermentation ... kefir grain and milk, with Lactococcus lactis subsp. lactis, ...
[50]
Milk kefir: composition, microbial cultures, biological activities, and ...
Oct 12, 2015 · Lactobacillus kefiri, Lactobacillus kefiranofaciens, Leuconostoc mesenteroides, Lactococcus lactis, Lactococcus lactis ssp. ... fermentation by ...
[51]
[PDF] Phylogenetic Diversity of the Bacterial Communities in Craft Beer
The bacterial community of chicha beer consists mainly of Lactobacillus fermentum, Lactococcus lactis, Leuconostoc mesenteroides, and. Streptococcus ...
[52]
Fermentation of plant‐based dairy alternatives by lactic acid bacteria
Apr 8, 2022 · (2021) Fermentation of gluten by Lactococcus lactis LLGKC18 reduces its antigenicity and allergenicity. ... (2009) Physical characteristics during ...
[53]
Versatile Lactococcus lactis strains improve texture in both ... - NIH
Dec 1, 2022 · Lactococcus lactis is used to produce numerous fermented dairy products including cheese and mesophilic fermented milk, such as buttermilk and ...
[54]
Nutritional value and sensory attributes of plant-based fermented milk
(2022) Fermentation of mung bean milk by Lactococcus lactis: focus on the physicochemical prop- erties, antioxidant capacities and sensory evaluation. Food.
[55]
Diversity Analysis of Dairy and Nondairy Lactococcus lactis Isolates ...
May 7, 2007 · The diversity of a collection of 102 lactococcus isolates including 91 Lactococcus lactis isolates of dairy and nondairy origin was explored ...
[56]
Surface Proteins of Lactococcus lactis: Bacterial Resources for Muco ...
Nov 23, 2017 · In this review, we describe the different types of surface proteins found in L. lactis, with a special focus on mucus-binding proteins and pili.
[57]
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling ...
In this review, we have discussed the ability of bacteriocin-producing probiotic lactic acid bacteria in the modulation of gut microbiota correcting dysbiosis.
[58]
Effects of an exopolysaccharide from Lactococcus lactis Z-2 on ...
Jan 22, 2020 · However, whether infected or not, the expression levels of anti-inflammatory cytokines (IL-10, TGF-β) were significantly increased in the EPS-2 ...
[59]
Effects of food containing Lactococcus lactis strain T21 on the ... - NIH
Aug 6, 2024 · This research aimed to examine the effect of daily intake of food containing Lactococcus lactis strain T21 (T21) on skin conditions and inflammation-related ...Missing: cranberry | Show results with:cranberry
[60]
Potential Anti-Allergy and Immunomodulatory Properties of ...
L. lactis LB 1022 significantly modulated AD-like symptoms by altering metabolites and the immune response, illustrating its potential as candidate for use in ...
[61]
In vitro assessment of hypocholesterolemic activity of Lactococcus ...
Apr 5, 2019 · Deconjugation of bile salt by bile salt hydrolase. The deconjugation activity of the isolated Lactococcus lactis subsp. lactis toward sodium ...<|control11|><|separator|>
[62]
[PDF] GRAS Notice (GRN) 1088 Agency Response Letter - FDA
1 The notice informs us of CBI's view that this use of L. lactis subsp. lactis KCTC. 11865BP is GRAS through scientific procedures. CBI describes L. lactis ...
[63]
A Randomized Double-blind Placebo-controlled Clinical Trial of ...
Feb 28, 2025 · During the 8-week intervention period, the experimental group consumed one capsule containing 1×1010 CFU of GCWB1176 daily, whereas the control ...
[64]
Indigenous Lactococcus lactis with Probiotic Properties - MDPI
Apr 30, 2022 · Immobilized L. lactis cells maintained viability at necessary levels (>6 log cfu/g) during storage and significantly increased the acceptability ...
[65]
Development of Lactococcus lactis encoding fluorescent proteins ...
Mar 20, 2017 · The reporter gene sequences were optimized to be expressed by L. lactis using inducible promoter pNis within the pNZ8048 vector. Expression of ...
[66]
Nisin inducible production of listeriolysin O in Lactococcus lactis ...
Jul 29, 2008 · We created a modified pNZ8048 vector encoding a six-His-tagged LLO downstream of the strong inducible PnisA promoter. Results. The constructed ...
[67]
Protection against tetanus toxin in mice nasally immunized with ...
Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine. 1997 Apr-May;15(6-7): ...Missing: study | Show results with:study
[68]
Protection against tetanus toxin in mice nasally immunized with ...
April–May 1997, ... Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.Missing: study | Show results with:study
[69]
Oral and intranasal immunization with food-grade recombinant ... - NIH
Our data demonstrate L.lactis expressing spike protein can be developed into a less invasive alternative to nasal and oral vaccination.Missing: 2022-2024 | Show results with:2022-2024
[70]
Oral Immunization of Mice with Cell Extracts from Recombinant ...
Apr 23, 2022 · The aim of the study is to develop and examine an oral vaccine against COVID-19 with recombinant Lactococcus lactis IL1403, a strain of lactic ...Missing: 2022-2024 | Show results with:2022-2024
[71]
Oral Administration of Recombinant Lactococcus lactis Expressing ...
Aug 26, 2014 · We observed that oral administration of recombinant L. Lactis resulted in the prevention of hyperglycemia, improved glucose tolerance and reduced insulitis.
[72]
Reversal of autoimmune diabetes by restoration of antigen-specific ...
Apr 9, 2012 · We developed a strategy for tolerance restoration using mucosal delivery in mice of biologically contained Lactococcus lactis genetically modified.
[73]
Treatment of murine colitis by Lactococcus lactis secreting ... - PubMed
Intragastric administration of IL-10-secreting Lactococcus lactis caused a 50% reduction in colitis in mice treated with dextran sulfate sodium.
[74]
Engineered Probiotic Lactococcus lactis for Lycopene Production ...
Mar 15, 2022 · This work established the use of the engineered probiotic L. lactis for lycopene production and prospected its potential in the prevention of intestinal ...
[75]
Enhanced gastrointestinal survivability of recombinant Lactococcus ...
Jul 23, 2019 · This study demonstrates the possibility of developing an orally administered live vaccine delivery approach employing recombinant L. lactis with ...
[76]
Therapeutic Drug Delivery by Genetically Modified Lactococcus lactis
Aug 4, 2025 · Food-grade bacteria have been consumed throughout history without associated pathologies and are, therefore, absolutely safe to ingest.
[77]
Oral Delivery of Lactococcus lactis Expressing Full-Length S Protein ...
Despite their potential advantages, oral vaccines face significant challenges in delivery and efficacy. The harsh conditions of the gastrointestinal tract ...
[78]
[PDF] One-plasmid based CRISPR-Cas9 editing for gene deletion in ...
In uence of lipoteichoic acid D-alanylation on protein secretion in Lactococcus lactis as revealed by random mutagenesis. Applied and Environmental ...
[79]
New Effective Method of Lactococcus Genome Editing Using Guide ...
Nov 12, 2022 · We recently employed a suggested system based on the CRISPR–Cas-associated transposon for the editing of the L. lactis genome.
[80]
Improvement of γ-aminobutyrate biosynthesis by genetically ...
Apr 15, 2020 · γ-Aminobutyrate (GABA) is an important bioactive compound synthesized through decarboxylation of L-glutamate by the glutamate decarboxylase (GAD).Missing: CRISPR | Show results with:CRISPR
[81]
Engineering Lactococcus lactis as a multi-stress tolerant ...
Dec 9, 2020 · This study aimed to construct a nisin-producing chassis Lactococcus lactis strain with genome-streamlined, low metabolic burden, and multi-stress tolerance ...
[82]
Analysis and Reconstitution of the Menaquinone Biosynthesis ...
Golden Gate Assembly was used to assemble the multiple DNA fragments and vector backbones in the form of synthetic operons encoding all six genes, with and ...
[83]
Development of a Golden Gate Assembly-Based Genetic Toolbox ...
Sep 10, 2024 · We therefore developed a modular and standardized Golden Gate Assembly-based toolbox for the de novo assembly of shuttle vectors from Escherichia coli to L. ...Missing: lactis | Show results with:lactis
[84]
Advances in biomanufacturing and recent biological applications of ...
Oct 27, 2025 · Metabolic engineering has led to important breakthroughs to further increase carotenoid production, providing significant advantages, including ...
[85]
Quantitative proteomics and integrated stress response analysis of ...
Quantitative proteomics and integrated stress response analysis of the ccpA mutant of Lactococcus lactis N8 ... 2024. TLDR. It is demonstrated that ΔAcrR1 ...
[86]
Integrated Transcriptomic and Proteomic Analyses Revealed the ...
Sep 5, 2025 · Overall, our findings deepen the current understanding of the stress response mechanisms in lactic acid bacteria and offer novel insights into ...
[87]
Fermented-Food Metagenomics Reveals Substrate-Associated ...
L. lactis dominated at the species level, corresponding to, on average, 44.8% of relative abundance and was present at a relative abundance at or above 90% ...
[88]
MiFoDB, a workflow for microbial food metagenomic ... - ASM Journals
Aug 19, 2025 · Metagenomics is a powerful approach to characterize microbes in fermented foods, providing high taxonomic resolution and functional insights.
[89]
Review Robustness: linking strain design to viable bioprocesses
Dec 10, 2021 · This review describes predictable and stochastic industrial perturbations as well as state-of-the-art technologies to counter process variability.
[90]
https://portlandpress.com/essaysbiochem/article/69/02/169/235765/Engineered-bacteria-and-bacterial-derivatives-as
[91]
Engineered bacteria and bacterial derivatives as advanced ...
Feb 27, 2025 · For example, modified strains of Lactococcus lactis secrete anti-inflammatory factors such as interleukin (IL)-10 or IL-27, which significantly ...
[92]
Safety Aspects of Genetically Modified Lactic Acid Bacteria - PMC
Feb 21, 2020 · This review presents data on the prospects for LAB to obtain 'generally recognized as safe' (GRAS) status.Missing: instability hurdles
[93]
Development of a Pre-Modification Strategy to Overcome Restriction ...
lactis are often hindered by challenges, such as genetic manipulation barriers, primarily due to the activity of the restriction–modification (RM) system in ...Missing: instability hurdles